Nonviral Vectors for Gene Therapy License:perpetual Presented are practical and principled

Presented are practical and principled aspects of technology

the myc oncogene

forming a major part of at least four regular international conference series

and success at work

which will save industry millions of dollars over time

Nonviral Vectors for Gene Therapy License:perpetual Presented are practical and principledGene transfer within humans has been an obstacle until about 10 years ago. At that time, it was found that viral vectors were effective carriers of "healthy genes" into patients' cells. The problem, however, was that viral vectors proved unnecessarily harmful to humans: subjects experienced inflamatory activity and negative immunological responses to the genes. Viral vectors were also unable to meet the needs of the pharmaceutical community: they were